首页> 外国专利> method for preparation of fluoreenderivaten, method for preparation of pharmaceutical preparations with anti - viruswerking, which thus prepared fluoreenderivaten containapplication of this method in pharmaceutical preparation was obtained.

method for preparation of fluoreenderivaten, method for preparation of pharmaceutical preparations with anti - viruswerking, which thus prepared fluoreenderivaten containapplication of this method in pharmaceutical preparation was obtained.

机译:本发明获得了一种含氟enderivaten的制备方法,具有抗病毒作用的药物制剂的制备方法,由此制得的氟enderivaten包含了该方法在药物制剂中的应用。

摘要

1,274,479. Fluorenone, fluorenol and fluorene derivatives. RICHARDSON-MERRELL Inc. 17 Dec., 1969 [30 Dec., 1968], No. 61592/69. Heading C2C. [Also in Division C4] The invention comprises novel compounds I (including acid addition salts and hydrates thereof) where Z is O, (H, H) or (H, OH), Y is O or S, and X is -A-NRRSP1/SP (A is C 2 to C 8 alkylene and separates the N and Y by at least 2 C, R and RSP1/SP are H, alkyl, C 3 to C 6 cycloalkyl, C 3 to C 6 alkenyl having the unsaturation in other than the 1-position of the alkenyl group, or together with the adjacent N comprise a saturated monocyclic heterocycle) or 1a where n is 0 to 2, m is 1 or 2 and RSP2/SP is H, alkyl or C 3 to C 6 alkenyl (same limitation as with the preceding alkenyl). The compounds are made by condensing II with (a) X-halogen, (b) halogen-A-halogen to afford compounds VI which are subsequently reacted with RRSP1/SPNH, or (c) R.RSP1/SP.NCO.ASP1/SP.- halogen or CNASP1/SP-halogen and reducing the intermediate (e.g. 2,7 - bis - (cyanomethoxy)- fluorene), so obtained with LiAlH, (A is ASP1/SPCH 2 ); the products I can be converted into other products I utilizing alkylation, reduction and/or oxidation. Pharmaceutical preparations showing, in particular, prophylactic and antiviral effects contain I as active ingredient; administration may be orally, parenterally and topically.
机译:1,274,479。芴酮,芴醇和芴衍生物。 RICHARDSON-MERRELL Inc.,1969年12月17日[1968年12月30日],编号61592/69。标题C2C。 [也在C4部分中]本发明包括新颖的化合物I(包括其酸加成盐和水合物),其中Z为O,(H,H)或(H,OH),Y为O或S,且X为-A- NRR 1 (A是C 2至C 8亚烷基,并且将N和Y隔开至少2个C,R和R 1 是H,烷基,C 3至C 6环烷基,在烯基的1位以外具有不饱和键的C 3至C 6烯基,或与相邻的N一起构成饱和单环杂环)或1a,其中n为0至2,m为1或2并且R 2 为H,烷基或C 3至C 6烯基(与前述烯基相同的限制)。通过将II与(a)X卤素,(b)卤素-A-卤素缩合得到化合物VI,然后使其与RR 1 NH或(c)RR 1 .NCO.A 1 .-卤素或CNA 1 -卤素并还原中间体(例如2,7-双-(氰基甲氧基)-芴),用LiAlH制成(A为A 1 CH 2);可以利用烷基化,还原和/或氧化将我的产品转化为其他产品。尤其显示出预防和抗病毒作用的药物制剂含有I作为活性成分。给药可以是口服,胃肠外和局部。

著录项

  • 公开/公告号NL163501C

    专利类型

  • 公开/公告日1980-09-15

    原文格式PDF

  • 申请/专利权人 RICHARDSON-MERRELL INC. NEW YORK.;

    申请/专利号NL19690019612

  • 发明设计人

    申请日1969-12-30

  • 分类号C07C93/06;C07D295/08;A61K31/13;A61K31/395;

  • 国家 NL

  • 入库时间 2022-08-22 18:29:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号